2016 Packaging Vaccines 
Express Pharma
DECEMBER 11, 2023
The COVID-19 pandemic also highlighted the vital role of the cold chain in ensuring patient safety during vaccine distribution. And, with India’s vaccine, biopharma, and clinical trials market projected to grow in double-digits, there will be an increasing demand for efficient cold chain facilities. billion in 2022.
pharmaphorum
APRIL 11, 2022
Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. At Janssen, we strive to improve access to our innovative medicines and vaccines and achieve the best possible outcomes for patients across the world.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaShots
APRIL 25, 2023
Founded Year: 2016 Total Employees: ~580 Headquarters: California, United States Market Cap: $3.4B The company strives to discover and develop therapeutic products under its business segments, including General Medicines, Specialty Medicines, and Vaccines. R&D Expenditure: $474.6M R&D Expenditure: $6.6B
PharmaShots
MARCH 9, 2023
Other Affiliations: Angela is an active Board of Director member of the Pfizer Foundation (a charitable organization addressing global health challenges), European Federation of Pharmaceutical Industries and Associations (EFPIA), and UPS (the global leader in package delivery and supply chain logistics). and Banco Bilbao Vizcaya Argentaria S.A
pharmaphorum
NOVEMBER 16, 2020
She first joined the EMA in 2002 and filled a number of senior roles at the regulator including head of inspections, head of international liaison and head of international affairs before switching to the WHO in 2016.
The Digital Apothecary
APRIL 26, 2019
This includes companies providing on-demand drug deliveries, alternative packaging solutions, or other personable entreaties to entice customers to get their medications filled at their location. The authors went back and analyzed much of the past data using previous methods to estimate costs in dollars and reflect inflation for 2016 prices.
pharmaphorum
AUGUST 16, 2022
One of the unexpected consequences of the COVID-19 vaccine race was that some top-tier vaccine companies like Merck, GSK and Sanofi ended up trailing the field, as their efforts to bring shots based on conventional technologies to patients were outstripped and outclassed by mRNA competitors from Pfizer/BioNTech and Moderna.
Expert insights. Personalized for you.
115 
Let's personalize your content